ADHD Part I: The Diagnosis, Treatment, and Management of Attention Deficit Hyperactivity Disorder (ADHD) in Children and Young Adults

Recorded—September 12, 2007 ¦ 7:00PM to 9:30PM Eastern time

Statement of Need

Attention Deficit Hyperactivity Disorder is a highly prevalent condition, with recent reports indicating rates ranging from 3 percent to 9 percent of the population, with higher incidences in school-age children. Application of World Health Organization (WHO) based criteria yielded a prevalence rate of 1.8% worldwide. ADHD in children and young adults is of major concern because of the correlation between ADHD and difficulties in learning, special skills attainment, and psychosocial refinement needed for success as adults. In many instances, pharmacologic intervention is recommended by the clinician, or desired (sometimes demanded) by the family and the child study team in an Individualized Education Program (IEP). For many years, principal medical management consisted of stimulant medications. In recent years, alternative medical strategies have emerged, including non-stimulant medications. Current data suggest that pharmacologic intervention in combination with effective psychosocial intervention can be both safe and efficacious. As such, a wide range of pharmacological interventions are available today to the clinician, but the need still exists for good, disciplined patient work-ups and differential diagnosis to establish baselines for each patient.

Conference Goal

The overall goal of this conference is to improve clinical knowledge, skills, and competency of healthcare professionals regarding evaluation and management of behavioral disorders - such as Autism - experienced by adults and children with developmental disabilities.

Educational Objectives

Upon completion of this educational activity, participants will be able to:

Discuss the hypothesized underlying basic biochemical and pathophysiological mechanisms that lead to ADHD in adults and children with developmental disabilities.
Describe how ADHD are diagnosed in adults and children with developmental disabilities.
Discuss various treatment/management strategies that may be effective in the overall treatment of ADHD encountered in adults and children with developmental disabilities.

Program Agenda and Faculty

: Introduction and Overview; Seth M. Keller, MD
Lecture 1: The Screening and Diagnosis of ADHD in Children and Young Adults; Thomas Gallagher, MD
Lecture 2: Understanding Children's Behavior: Nonpharmacologic management of challenging ADHD symptoms at home and in the Classroom.; Pasquale Accardo, MD
: Questions and Discussion

Click here to view the archived event

Faculty

Seth M. Keller, MD (Moderator): Consultant in Neurology
NJ Department of Human Services,
Division of Developmental Disabilities,
Trenton, NJ

Pasquale Accardo, MD: James H. Franklin Professor of Developmental Research in Pediatrics,
Virginia Commonwealth University School of Medicine
Richmond, VA

Thomas Gallagher, MD: Clinical Professor,
John A. Burns School of Medicine (JABSOM),
University of Hawaii,
Honolulu, Hawaii
Associate Clinical Professor,
Uniformed Services University Health Sciences (USUHS)
Bethesda, Maryland

The Rady Children's Hospital-San Diego reserves the right to modify the program contents, faculty, and program activities. It also reserves the right to cancel the program if necessary.

Grantor Support: These programs are funded as part of a U.S. Army Cooperative Agreement called the Exceptional Family Transitional Training (EFTT) Program. The programs are co-sponsored by the American Academy of Developmental Medicine and Dentistry (AADMD) and EP LiveOnline.
Registration: There is no registration fee to participate in this program.
Who Should Attend: Pediatricians, Internists, Family Practitioners, Neurologists, Psychiatrists, Nurses, and other health professionals who provide services to adults and children with developmental disabilities.
Accreditation Statement: The Rady Children's Hospital-San Diego is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians.; The American Academy of Developmental Medicine & Dentistry is accredited by the Medical Society of New Jersey (MSNJ) to provide continuing education for physicians.
Credit Designation Statement: The Rady Children's Hospital-San Diego designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Instructions to Receive Credit: In order to receive AMA PRA Category 1 Credits, physicians must attend the entire 2.5 hour conference and complete the CME Evaluation Form. This form will be made available at the time of the online conference.
Disclosure Policy: The Rady Children's Hospital-San Diego requires that faculty participating in a CME activity disclose to the audience any relationship with a pharmaceutical or equipment company that might pose a potential, apparent, or real conflict of interest with regard to their contribution to the program. This information will be made available to the audiences prior to the presentation.
Activity Co-Directors: R.R. Skoglund, MD; Director, Continuing Medical Education
Rady Children's Hospital-San Diego,
San Diego, California; Henry Chambers, MD; Rady Children's Hospital-San Diego,
San Diego, California; Philip B. May, MD; Clinical Associate Professor
Department of Medicine,
UMDNJ-Robert Wood Johnson Medical School
Director of Medical Education and VP for Education/Research
American Academy of Developmental Medicine and Dentistry
Assistant Medical Director,
Hunterdon Developmental Center